TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma.

S-E Al-Batran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.